Filing Details

Accession Number:
0001209191-15-071693
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-21 17:35:17
Reporting Period:
2015-09-17
Filing Date:
2015-09-21
Accepted Time:
2015-09-21 17:35:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402604 Gil Bokkelen Van 3201 Carnegie Avenue
Cleveland OH 44115-2634
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-17 3,727 $1.45 930,192 No 4 F Direct
Common Stock Disposition 2015-09-18 4,750 $1.38 925,442 No 4 S Direct
Common Stock Disposition 2015-09-18 19,027 $1.35 906,415 No 4 F Direct
Common Stock Disposition 2015-09-21 4,750 $1.33 901,665 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld from the quarterly vesting of a June 2014 and a June 2015 restricted stock unit award related to the minimum tax withholding obligation.
  2. Shares sold pursuant to a predefined Rule 10b5-1 trading plan solely related to the tax obligation on the quarterly vesting of a June 2013 restricted stock unit award.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.49, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted for tax and planning purposes.
  4. Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award related to the minimum tax withholding obligation.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.315 to $1.38, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
  6. Securities beneficially owned are comprised of: (1) 580,765 shares of common stock owned, (2) 173,760 restricted stock units awarded on June 20, 2013 related to the termination of 2005 incentive agreements that will vest ratably on a quarterly basis through June 18, 2016, and (3) restricted stock units awarded on an annual basis amounting to 147,140 that vest quarterly over a four-year period from grant date.